PDP-DESONIDE 0.05 %
DESONIDE : 0.05 % · DIN 02229315 · PENDOPHARM DIVISION OF PHARMASCIENCE INC
Health Canada status: MARKETED
What is PDP-DESONIDE?
PDP-DESONIDE 0.05 % contains DESONIDE : 0.05 %. It is listed in the Health Canada Drug Product Database under DIN 02229315, held by PENDOPHARM DIVISION OF PHARMASCIENCE INC, supplied as CREAM for TOPICAL administration. Health Canada currently lists it as marketed, status dated 25-Sep-2015. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02229315 |
|---|---|
| Brand name | PDP-DESONIDE |
| Generic / active ingredient | DESONIDE : 0.05 % |
| Manufacturer | PENDOPHARM DIVISION OF PHARMASCIENCE INC |
| Strength | 0.05 % |
| Dosage form | CREAM |
| Route of administration | TOPICAL |
| Schedule | Prescription |
| ATC code | D07AB08 DESONIDE |
| AHFS class | 84:06.00 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 25-Sep-2015 |
| Original market date | 1997-01-14 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code D07AB08 DESONIDE. 2 of 12 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| PDP-DESONIDE | 0.05 % | OINTMENT | PENDOPHARM DIVISION OF PHARMASCIENCE INC | MARKETED | DIN 02229323 |
| DESOCORT CREAM 0.05% | .05 % | CREAM | GALDERMA CANADA INC | CANCELLED POST MARKET | DIN 02048639 |
| DESOCORT LOTION - 0.05% | .05 % | LOTION | GALDERMA CANADA INC | CANCELLED POST MARKET | DIN 02115514 |
| DESOCORT OINTMENT - 0.05% | .05 % | OINTMENT | GALDERMA CANADA INC | CANCELLED POST MARKET | DIN 02115522 |
| PMS-DESONIDE | 0.05 % | OINTMENT | PHARMASCIENCE INC | APPROVED | DIN 02516357 |
| PMS-DESONIDE | 0.05 % | CREAM | PHARMASCIENCE INC | APPROVED | DIN 02516349 |
| TRIDESILON 0.05% DESONIDE CREAM | 0.05 % | CREAM | PERRIGO INTERNATIONAL | CANCELLED POST MARKET | DIN 02154862 |
| TRIDESILON 0.05% DESONIDE OINTMENT | 0.05 % | OINTMENT | PERRIGO INTERNATIONAL | CANCELLED POST MARKET | DIN 02154870 |
| TRIDESILON CRM 0.05% | .5 MG | CREAM | MILES CANADA INC. - PHARMACEUTICAL DIVISION | CANCELLED POST MARKET | DIN 00521248 |
| TRIDESILON ONT 0.05% | .5 MG | OINTMENT | MILES CANADA INC. - PHARMACEUTICAL DIVISION | CANCELLED POST MARKET | DIN 00521264 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.